Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma ; volume:43 ; number:1 ; day:6 ; month:8 ; year:2024 ; pages:1-17 ; date:12.2024
Journal of experimental & clinical cancer research ; 43, Heft 1 (6.8.2024), 1-17, 12.2024
- Creator
-
Chen, Hsien-Chung
Lin, Hong-Yi
Chiang, Yung-Hsiao
Yang, Wen-Bin
Wang, Chung-Han
Yang, Pei-Yu
Hu, Siou-Lian
Hsu, Tsung-I
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-024-03144-2
- URN
-
urn:nbn:de:101:1-2410262100124.133544215663
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Hsien-Chung
- Lin, Hong-Yi
- Chiang, Yung-Hsiao
- Yang, Wen-Bin
- Wang, Chung-Han
- Yang, Pei-Yu
- Hu, Siou-Lian
- Hsu, Tsung-I
- SpringerLink (Online service)
Other Objects (12)
Progesterone Treatment Attenuates Glycolytic Metabolism and Induces Senescence in Glioblastoma
Outsmarting trogocytosis to boost CAR NK/T cell therapy
Editorial: Advanced Cell Culture Technologies to Boost Cell-Based Therapies
Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies
Emerging therapies for glioblastoma: current state and future directions
Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?
A prospective comparison of adaptive and fixed boost plans in radiotherapy for glioblastoma
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
"BLiNK BLiNK"
Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies
Progesterone from Mexican Yams
Total Synthesis of (±)-Progesterone
Progesterone Treatment Attenuates Glycolytic Metabolism and Induces Senescence in Glioblastoma
Outsmarting trogocytosis to boost CAR NK/T cell therapy
Editorial: Advanced Cell Culture Technologies to Boost Cell-Based Therapies
Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies
Emerging therapies for glioblastoma: current state and future directions
Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?
A prospective comparison of adaptive and fixed boost plans in radiotherapy for glioblastoma
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
"BLiNK BLiNK"
Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies
Progesterone from Mexican Yams
Total Synthesis of (±)-Progesterone
Progesterone Treatment Attenuates Glycolytic Metabolism and Induces Senescence in Glioblastoma
Outsmarting trogocytosis to boost CAR NK/T cell therapy
Editorial: Advanced Cell Culture Technologies to Boost Cell-Based Therapies
Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies
Emerging therapies for glioblastoma: current state and future directions
Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?
A prospective comparison of adaptive and fixed boost plans in radiotherapy for glioblastoma
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
"BLiNK BLiNK"
Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies
Progesterone from Mexican Yams